Stocktoria

SHOULDER INNOVATIONS, INC. SI

NYSE · XNYS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2025-07-31
Chart by TradingView
4/9
Piotroski F — financial health
7.68
Altman Z″ — distress risk · safe
Dividend payout · no dividend

Financials & ratios (annual, from 10-K)

MetricFY2025FY2024
Financials
Revenue$47.3M$31.6M
Gross profit$36.2M$24.3M
Operating income-$26.3M-$14.7M
Net income-$40.4M-$15.6M
Operating cash flow-$28.6M-$14.1M
Free cash flow-$36.0M-$18.2M
Total assets$169.9M$43.1M
Total liabilities$29.2M$23.3M
Shareholders' equity$140.8M-$54.7M
Ratios
Gross margin76.5%77.0%
Operating margin-55.6%-46.3%
Net margin-85.3%-49.4%
FCF margin-76.1%-57.4%
Return on assets-23.8%-36.3%
Return on equity-28.7%28.6%
Debt / equity0.11×-0.27×
Current ratio11.074.59
Revenue growth49.6%

Why these scores methodology →

Piotroski F-score: 4/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: 7.68 (safe)

  • Working capital / assets 0.841
  • Retained earnings / assets -0.573
  • EBIT / assets -0.155
  • Equity / liabilities 4.827

Sector peers

VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →

Source: SEC EDGAR filings · CIK 0001699350 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.